跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLUDARABINE PHOSPHATE POWDER FOR SOLUTION FOR INJECTION/ INFUSION USP - HSA Drug Approval Details
Approvals
/
HSA
/
FLUDARABINE PHOSPHATE POWDER FOR SOLUTION FOR INJECTION/ INFUSION USP
Approved
THERAPEUTIC
FLUDARABINE PHOSPHATE POWDER FOR SOLUTION FOR INJECTION/ INFUSION USP
FRESENIUS KABI ONCOLOGY LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 8, 2016
Approval ID
437b919fd75be313
Company
FRESENIUS KABI ONCOLOGY LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
437b919fd75be313
Drug Name
FLUDARABINE PHOSPHATE POWDER FOR SOLUTION FOR INJECTION/ INFUSION USP
Product Name
FLUDARABINE PHOSPHATE POWDER FOR SOLUTION FOR INJECTION/ INFUSION USP
Approval Number
SIN15030P
Approval Date
2016-06-08
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BB05
Atc Item Name
fludarabine
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
Fludarabine Phosphate USP
50 mg/ vial
FLUDARABINE PHOSPHATE USP
50 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 8, 2016
Approval ID
437b919fd75be313
Type
Therapeutic
Back to HSA Approvals
